View Archive |
Home
| Industry News
RainDance signs agreement with Sanofi & Louis Pasteur
Oct 08
RainDance Technologies announced today the launch of the dScreen Consortium, a research initiative conducted with sanofi-aventis, Paris, and Louis Pasteur University of Strasbourg, France, to develop the next generation of high-throughput screening (HTS) for drug discovery applications. more...New Enterprise Electronic Lab Notebook...
Oct 08
Symyx Technologies, Inc. has announced the availability of Symyx Notebook - a new, enterprise electronic laboratory notebook (ELN) that is configurable to meet the needs of biologists and analytical chemists out-of-the-box.more...
Disease diagnosis in just 15 minutes
Oct 08
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
more...
ThromboGenics' Results in the Treatment of Acute Stroke
Oct 08
Results presented at World Stroke Congress in Vienna
Leuven, Belgium – September 29, 2008 - ThromboGenics NV, a biotechnology company focused on novel therapies for eye disease, vascular disease and cancer, announces positive results from its MITI IV Phase II trial to evaluate the safety and preliminary efficacy of microplasmin when administered intravenously to acute stroke patients. more...
More Links:
- Shionogi Extends Partnership with MorphoSys
- Gender differences in rheumatism
- ART makes another Quantum Leap
- CO Based Therapies Take Giant Leap
- Asterand Enter Into Agreement with Allergan
- Syntropharma closes £1.25 million funding
- DIDGERIDOO OR DIDGERIDREAMS?
- Genera's Genotyping Assay
- SBS/ELRIG BOURNEMOUTH 2008
- Molecular Profiles Showcases New Services
- Roche NimbleGen tackles bottleneck
- Syft Technologies on the FDA trail
- Symyx Launches Research Services
- Ablynx for Alzheimers Disease
- Gyrolab provides strategic advantage to PPM
- Cambridge Consultants' Vena platform